Deciphering the role of KRAS gene in oncogenesis: Focus on signaling pathways, genetic alterations in 3’UTR, KRAS specific miRNAs and therapeutic interventions
- 22 December 2023
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 194, 104250
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- RAS Interaction with PI3K: More Than Just Another Effector PathwayGenes & Cancer, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Clinical Relevance of KRAS in Human CancersJournal of Biomedicine and Biotechnology, 2010
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non–Small Cell Lung Cancer RiskCancer Research, 2008
- Ras oncogenes and their downstream targetsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Germline Missense Mutations Affecting KRAS Isoform B Are Associated with a Severe Noonan Syndrome PhenotypeThe American Journal of Human Genetics, 2006
- G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcriptionNucleic Acids Research, 2006